All stories tagged :

Sample Category Title

AVITA Medical Receives CE Mark for RECELL® GO, Enabling Commercialization Across...

admin
Pr Newswire

Tempest Announces $4.6 Million Registered Direct Offering of Common Stock

admin
Pr Newswire

Chiesi Group Enters into Worldwide Licensing Agreement with Key2Brain AB to...

admin
Pr Newswire

uniQure Announces Appointment of Kylie O’Keefe as Chief Customer and...

admin
Pr Newswire

Chiesi Group Enters into Worldwide Licensing Agreement with Key2Brain AB to...

admin
Pr Newswire

vTv Therapeutics to Participate in the H.C. Wainwright “HCW@Home” Series

admin
Pr Newswire

Ping An Good Doctor Revamps Brand and Launches Annual Healthcare Service...

admin
Pr Newswire

S&P and Moody’s Upgrade Emaar’s Credit Ratings, Citing Strong Financial Performance...

admin
Pr Newswire

S&P and Moody’s Upgrade Emaar’s Credit Ratings, Citing Strong Financial Performance...

admin
Pr Newswire

S&P and Moody’s Upgrade Emaar’s Credit Ratings, Citing Strong Financial Performance...

admin
Pr Newswire

Bybit Fast Tracks Payment and Spending Rewards with Unified Program for...

admin

Featured

Pr Newswire

Real-World Evidence of NEFECON® to Be Presented in Seven New Abstracts...

admin
Pr Newswire

Virtual IT Group and The Instillery Go to Town on Zero...

admin
Pr Newswire

HKUST Deepens Sweden Ties Positioning Hong Kong as a Strategic Nexus...

admin
Pr Newswire

Monopar to Present New Long-Term Neurological Efficacy and Safety Data for...

admin
admin

Real-World Evidence of NEFECON® to Be Presented in Seven New Abstracts...

7 new NEFECON® real-world evidence abstracts will be presented at the 18th International lgA Nephropathy Symposium (IIgANN 2025). The newly released results, based on clinical practices at several leading hospitals in China, offer a comprehensive overview of the efficacy and safety of NEFECON® in the treatment of IgA...